Related Experiment Video
Updated: Jun 15, 2025

Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Substance-induced mental disorders and discontinuation of medication for opioid use disorder
Alyssa Shell Tilhou1, Richard A Grucza2, Kevin Y Xu3
1Department of Family Medicine, Dowling Building, Boston Medical Center, 850 Harrison Ave, Boston, MA 02118, USA.
Background:
People with opioid use disorder (OUD) often exhibit psychiatric symptoms representing primary (PMD) and substance induced mental disorders (SIMD). PMD are associated with increased discontinuation of medications for OUD (MOUD). It is unknown if this relationship holds for SIMD.
Objective:
To examine the association between SIMD and time to MOUD discontinuation.
Methods:
In this retrospective cohort study using the Merative™ MarketScan® Commercial and Multi-State Medicaid insurance claims Databases (2015-2019), we identified individuals initiating MOUD (buprenorphine, methadone, and extended-release naltrexone) following a 180-day pre-period of continuous enrollment without MOUD. Episodes were classified based on > 1 SIMD diagnosis in this pre-period. We estimated days to MOUD discontinuation using stepwise multivariable Cox regression, adjusting for age, sex, insurance type (Medicaid or Commercial), Charlson Comorbidity Index, MOUD at initiation, co-occurring substance use disorders (SUD), and PMD.
Results:
Of 31,134 MOUD initiation episodes, 3.5 % exhibited SIMD. Episodes with SIMD demonstrated a higher prevalence (p < .001 for all) of mood and psychotic disorders (42.8 vs 16.4 %; 4.0 % vs 0.7 % respectively) but lower prevalence of anxiety-related disorders (51.3 % vs 59.9 %) relative to episodes without SIMD. Unadjusted models illustrated a 44 % (95 %CI:1.34-1.55) increased hazard of MOUD discontinuation associated with SIMD. After adjusting for all covariates but PMD, SIMD retained a 13 % increased hazard of MOUD discontinuation (95 %CI:1.05-1.21). Adjusting for PMD eliminated this association.
Conclusion:
SIMD is associated with reduced time to MOUD discontinuation, which may be accounted for by PMD. Further research on SIMD treatment among individuals with OUD is needed to improve OUD treatment outcomes.
More Related Videos
08:05A Prediction Error-driven Retrieval Procedure for Destabilizing and Rewriting Maladaptive Reward Memories in Hazardous Drinkers
Published on: January 5, 2018
16:02Demonstration of the Sequence Alignment to Predict Across Species Susceptibility Tool for Rapid Assessment of Protein Conservation
Published on: February 10, 2023
Related Concept Videos
Substance Use Disorders Affecting Sleep
Understanding the concepts of physical dependence,...
Drug Abuse and Addiction: Pharmacological Phenomena
Drug Dependence
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Mania and Antimanic Drugs: Overview
CNS Depressants: Barbiturates and Benzodiazepines